retatrutide dosing clinical trial retatrutide Phase III study demonstrates 30% weight loss Retatrutide Dosage: a Guide -

Clinical observations describing reduced protein intake, variability in lean mass trajectories, and micronutrient insufficiency during pharmacologically induced weight loss [40, 75, 94, 95] suggest that long-term metabolic stability may become sensitive to substrate availability even in the absence of overt deficiency

So, theres a risk there

Hence, oral GLP-1 drugs are a way for the industry to expand the market for GLP-1 agonists through an additional route of administration, albeit a route that may be attractive to people earlier in their disease journey

Dose (mg)

While the results in AD models are mixed, with benefits varying between specific models, GLP-1RAs show consistent neuroprotective effects in PD models, protecting dopaminergic neurons and reducing inflammation